{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:43:35Z","timestamp":1777445015324,"version":"3.51.4"},"reference-count":69,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ex 60 DSCB - University of Turin","award":["MORA_RILO_17_01"],"award-info":[{"award-number":["MORA_RILO_17_01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Nuclear-cytoplasmic shuttling is a highly regulated and complex process, which involves both proteins and nucleic acids. Changes in cellular compartmentalization of various proteins, including oncogenes and tumor suppressors, affect cellular behavior, promoting or inhibiting proliferation, apoptosis and sensitivity to therapies. In this review, we will recapitulate the role of various shuttling components in Chronic Myeloid Leukemia and we will provide insights on the potential role of shuttling proteins as therapeutic targets.<\/jats:p>","DOI":"10.3390\/cells8101248","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T03:54:13Z","timestamp":1571025253000},"page":"1248","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-6800","authenticated-orcid":false,"given":"Giovanna","family":"Carr\u00e0","sequence":"first","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2921-1763","authenticated-orcid":false,"given":"Isabella","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Guerrasio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-2903","authenticated-orcid":false,"given":"Alessandro","family":"Morotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fu, X., Liang, C., Li, F., Wang, L., Wu, X., Lu, A., Xiao, G., and Zhang, G. (2018). The Rules and Functions of Nucleocytoplasmic Shuttling Proteins. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051445"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbagrm.2017.11.007","article-title":"tRNA dynamics between the nucleus, cytoplasm and mitochondrial surface: Location, location, location","volume":"1861","author":"Chatterjee","year":"2018","journal-title":"Biochim. Et Biophys. Acta (Bba) - Gene Regul. Mech."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Vindry, C., Weil, D., and Standart, N. (2019). Pat1 RNA-binding proteins: Multitasking shuttling proteins. Wiley Interdiscip. Rev.: RNA, e1557.","DOI":"10.1002\/wrna.1557"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1158\/1078-0432.CCR-15-0408","article-title":"Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling","volume":"21","author":"Conforti","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gravina, G.L., Senapedis, W., McCauley, D., Baloglu, E., Shacham, S., and Festuccia, C. (2014). Nucleo-cytoplasmic transport as a therapeutic target of cancer. J. Hematol. Oncol., 7.","DOI":"10.1186\/s13045-014-0085-1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa1903455","article-title":"Oral Selinexor\u2013Dexamethasone for Triple-Class Refractory Multiple Myeloma","volume":"381","author":"Chari","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc2145","article-title":"Changing venues for tumour suppression: Balancing destruction and localization by monoubiquitylation","volume":"7","author":"Salmena","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Crivellaro, S., Carr\u00e0, G., Panuzzo, C., Taulli, R., Guerrasio, A., Saglio, G., and Morotti, A. (2016). The non-genomic loss of function of tumor suppressors: An essential role in the pathogenesis of chronic myeloid leukemia chronic phase. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2346-6"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/sctm.17-0175","article-title":"Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment","volume":"7","author":"Arrigoni","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1196\/annals.1322.050","article-title":"Rational approaches to the design of therapeutics targeting molecular markers: The case of chronic myelogenous leukemia","volume":"1028","author":"Saglio","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14712598.2014.867323","article-title":"Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemia","volume":"14","author":"Morotti","year":"2014","journal-title":"Expert Opin. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.beha.2016.10.005","article-title":"Management of CML-blast crisis","volume":"29","author":"Hehlmann","year":"2016","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/j.1460-2075.1996.tb00503.x","article-title":"The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products","volume":"15","author":"Wen","year":"1996","journal-title":"Embo J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1073\/pnas.95.13.7457","article-title":"Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase","volume":"95","author":"Taagepera","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/387516a0","article-title":"Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation","volume":"387","author":"Baskaran","year":"1997","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/j.1460-2075.1993.tb05797.x","article-title":"An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias","volume":"12","author":"McWhirter","year":"1993","journal-title":"Embo J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Preyer, M., Vigneri, P., and Wang, J.Y.J. (2011). Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017020"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/84683","article-title":"Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR\u2013ABL tyrosine kinase","volume":"7","author":"Vigneri","year":"2001","journal-title":"Nat. Med."},{"key":"ref_21","first-page":"7587","article-title":"A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins","volume":"13","author":"McWhirter","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood-2005-05-2123","article-title":"BCR-ABL nuclear entrapment kills human CML cells: Ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B","volume":"107","author":"Aloisi","year":"2006","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: New modes and prospects","volume":"19","author":"Lee","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1242\/jcs.022459","article-title":"The nuclear affairs of PTEN","volume":"121","author":"Planchon","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature07290","article-title":"The deubiquitinylation and localization of PTEN are regulated by a HAUSP\u2013PML network","volume":"455","author":"Song","year":"2008","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","article-title":"Ubiquitination regulates PTEN nuclear import and tumor suppression","volume":"128","author":"Trotman","year":"2007","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1236188","article-title":"Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress","volume":"341","author":"Bassi","year":"2013","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/leu.2013.370","article-title":"BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP","volume":"28","author":"Morotti","year":"2014","journal-title":"Leukemia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ejh.12422","article-title":"HAUSP compartmentalization in chronic myeloid leukemia","volume":"94","author":"Morotti","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tcb.2008.07.004","article-title":"Unravelling the tumor-suppressive functions of FOXO proteins","volume":"18","author":"Dansen","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: Signalling integrators for homeostasis maintenance","volume":"14","author":"Eijkelenboom","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcancer.2017.11.017","article-title":"Re-evaluating the role of FOXOs in cancer","volume":"50","author":"Hornsveld","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7150\/ijbs.20052","article-title":"FOXO Signaling Pathways as Therapeutic Targets in Cancer","volume":"13","author":"Farhan","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/stem.1748","article-title":"The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors","volume":"32","author":"Pellicano","year":"2014","journal-title":"Stem Cells"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj20040167","article-title":"The ins and outs of FoxO shuttling: Mechanisms of FoxO translocation and transcriptional regulation","volume":"380","author":"Hoekman","year":"2004","journal-title":"Biochem. J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cautain, B., Castillo, F., Musso, L., Ferreira, B.I., de Pedro, N., Quesada, L.R., Machado, S., Vicente, F., Dallavalle, S., and Link, W. (2016). Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167491"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1242\/jcs.064501","article-title":"p53 at a glance","volume":"123","author":"Brady","year":"2010","journal-title":"J. Cell. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07986","article-title":"Cytoplasmic functions of the tumour suppressor p53","volume":"458","author":"Green","year":"2009","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1128\/MCB.23.18.6396-6405.2003","article-title":"Nucleocytoplasmic Shuttling of p53 Is Essential for MDM2-Mediated Cytoplasmic Degradation but Not Ubiquitination","volume":"23","author":"Li","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14616","DOI":"10.1074\/jbc.M610515200","article-title":"Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination","volume":"282","author":"Nie","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2016.1272682","article-title":"Induction of p53 suppresses chronic myeloid leukemia","volume":"58","author":"Peterson","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/stem.5530130416","article-title":"Role of p53 in leukemogenesis of chronic myeloid leukemia","volume":"13","author":"Lanza","year":"1995","journal-title":"Stem Cells"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25217","DOI":"10.18632\/oncotarget.4611","article-title":"Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes I\u03baB\u03b1 mediated p53 nuclear exclusion","volume":"6","author":"Crivellaro","year":"2015","journal-title":"Oncotarget"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1158\/0008-5472.CAN-09-0548","article-title":"Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity","volume":"69","author":"Skorta","year":"2009","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/15384101.2016.1157238","article-title":"The non-canonical functions of p27(Kip1) in normal and tumor biology","volume":"15","author":"Sharma","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2018.07.008","article-title":"Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein","volume":"69","author":"Abbastabar","year":"2018","journal-title":"Dna Repair (Amst.)"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1182\/blood-2013-04-497040","article-title":"BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein","volume":"124","author":"Agarwal","year":"2014","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Roy, A., Lahiry, L., Banerjee, D., Ghosh, M., and Banerjee, S. (2013). Increased cytoplasmic localization of p27(kip1) and its modulation of RhoA activity during progression of chronic myeloid leukemia. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076527"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc2824","article-title":"Translational control in cancer","volume":"10","author":"Silvera","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrc1015","article-title":"Does the ribosome translate cancer?","volume":"3","author":"Ruggero","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1158\/1078-0432.CCR-06-2320","article-title":"From mRNA metabolism to cancer therapy: Chronic myelogenous leukemia shows the way","volume":"13","author":"Perrotti","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2007-05-090472","article-title":"Identification of novel posttranscriptional targets of the BCR\/ABL oncoprotein by ribonomics: Requirement of E2F3 for BCR\/ABL leukemogenesis","volume":"111","author":"Eiring","year":"2008","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/10428194.2010.546914","article-title":"BCR\u2013ABL1 kinase-dependent alteration of mRNA metabolism: Potential alternatives for therapeutic intervention","volume":"52","author":"PERROTTI","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1083\/jcb.137.1.27","article-title":"A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export","volume":"137","author":"Izaurralde","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/355730a0","article-title":"Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm","volume":"355","author":"Dreyfuss","year":"1992","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/jmbi.1993.1127","article-title":"Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter","volume":"230","author":"Biamonti","year":"1993","journal-title":"J. Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1128\/MCB.22.7.2255-2266.2002","article-title":"hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR\/ABL Leukemogenesis","volume":"22","author":"Iervolino","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","first-page":"724","article-title":"Identification of hnRNP P2 as TLS\/FUS using electrospray mass spectrometry","volume":"1","author":"Calvio","year":"1995","journal-title":"RNA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/363640a0","article-title":"Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma","volume":"363","author":"Crozat","year":"1993","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1093\/emboj\/17.15.4442","article-title":"TLS\/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR\/ABL-mediated leukemogenesis","volume":"17","author":"Perrotti","year":"1998","journal-title":"Embo J."},{"key":"ref_64","first-page":"1815","article-title":"Focus on exosomes: Novel pathogenic components of leukemia","volume":"9","author":"Yang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/ijc.26217","article-title":"Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis","volume":"130","author":"Taverna","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1476-4598-13-169","article-title":"Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells","volume":"13","author":"Taverna","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"34343","DOI":"10.1074\/jbc.M113.480822","article-title":"Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells","volume":"288","author":"Tadokoro","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/onc.2012.295","article-title":"Leukemia cell to endothelial cell communication via exosomal miRNAs","volume":"32","author":"Umezu","year":"2013","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1196\/annals.1339.002","article-title":"Cytoplasmic\/nuclear shuttling and tumor progression","volume":"1059","author":"Wang","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/10\/1248\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:56Z","timestamp":1760189156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/10\/1248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["cells8101248"],"URL":"https:\/\/doi.org\/10.3390\/cells8101248","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]}}}